polyostotic fibrous dysplasia
MeSH: D005359ORPHA: 932762 Treatments Available
Overview
autosomal dominant disease that involves skin pigmentation, bone and hormonal problems along with premature puberty
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Denosumab Cold Chain | Subcutaneous injection, 120mg/1.7mL solution | FDA Approved | 7 | 14d |
| Pamidronate | IV infusion, 30mg, 60mg, 90mg powder for reconstitution | FDA Approved | 10 | 7d |
Classification & Codes
MeSH Code
D005359Orphanet Code
ORPHA:93276polyostotic fibrous dysplasia
| MeSH | D005359 |
| Orphanet | ORPHA:93276 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO